⌘K

Login Start Free

Home/Filings/4/0001387131-17-000673

4//SEC Filing

Adamis Pharmaceuticals Corp 4

Accession 0001387131-17-000673

CIK 0000887247operating

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:01 PM ET

Size

5.5 KB

Accession

0001387131-17-000673

Insider Transaction Report

Form 4

Period: 2017-02-07

Adamis Pharmaceuticals CorpADMP

Vice President of Research

Transactions

Award
Employee Stock Option (right to buy)
2017-02-07+110,000→ 110,000 total
Exercise: $3.15Exp: 2027-02-07→ Common Stock (110,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.

Documents

1 file

4
moll-form4_020717.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887247

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 5:01 PM ET
Size: 5.5 KB

View on SEC.gov